Pharma prices will attract US political attention

Scientific advances are impressive, but the ability to pay for them without bankrupting the health system is in question

You must be signed in to read this analysis

Sign in Sign up to our newsletter

In this article

  • Expensive cures
  • Private and public pressures
  • Industry pricing
  • Mergers and acquisitions
  • Outlook

What is this?

This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.